The series is stated in the current share scale after splits; dividends are not included in the price
Elevance Health is a health insurer operating under the Blue Cross Blue Shield brand in fourteen states.
The model is every health insurer's: collect premiums, pay for care, earn on the difference. The key metric is the share of premiums spent on claims: a couple of percentage points move profit more than membership growth does.
Rights to the Blue Cross brand in assigned states are a substantial asset: brand recognition and agreements with local doctors and hospitals are hard for a new entrant to replicate. Government programmes for the elderly and low-income supply a meaningful share of revenue and the main regulatory risk at once.
The company is building its own care services and pharmacy arm, following competitors toward vertical integration. Risks: revisions to government programme rates, rising utilisation and regulatory attention to coding practices. Elevance pays a dividend.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Elevance Health, Inc. (ELV) is a company in the Health care sector; its shares trade on NYSE.
The price of Elevance Health, Inc. (ELV) on October 30, 2026 is 420.52 $, −0.36 % on the day. Over 52 weeks the stock traded between 274.84 $ and 436.24 $; the price now sits 90 % of the way up that range. Over the past year the price changed by +22.59 %. The P/E ratio is 18.37, which is below the sector median (24.61). Market capitalization is 91.19 billion $, rank 2 among 9 stocks of the same industry with a known capitalization.
Elevance Health, Inc. trades on NYSE under the ticker ELV. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks ELV has traded between 274.84 $ and 436.24 $. As of 30 October 2026 the price stood 95.16 % of the way from the 52-week low to the high.
Over one year ELV shares rose 22.59 %; over six months they rose 35.66 %. Volatility over 90 days is 32.96 %. Dividends are not included: this is price change only, as of 30 October 2026.
ELV trades at a price-to-earnings ratio of 18.4, below the sector median of 24.6. Price to sales is 0.5, below the sector median of 3.6. Price to book is 2.0, below the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
Elevance Health, Inc. reported revenue of 201.1B $ and net income of 5.0B $ over the last four quarters. Net margin is 2.47 %. Revenue changed by +6.29 % year over year. Earnings per share are 22.61 $. Market capitalisation is 91.2B $.
ELV has a return on equity of 11.06 %, above the sector median of −40.58 %. Return on assets is 3.93 %, above the sector median of −30.08 %.
